|
Summary Information: Xenetic Biosciences Inc. Common Stock NASDAQ:XBIO |
  [email protected] |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART™ has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications.
__The following are links to various summary and news pages for __Xenetic Biosciences Inc. Common Stock [ XBIO ]. __Note: Some Links might not have information for the company. |
|